1. 382PDSecond-line treatment of bevacizumab plus lomustine versus bevacizumab plus irinotecan in patients with recurrent glioblastoma. (23rd October 2018) Authors: Simões, J; Tavares, N T; Borges, C; Meireles, S; Fernandes, C; Costa, A; Caeiro, C; Damasceno, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 389PBevacizumab-induced hypertension correlation with survival in recurrent glioblastoma multiforme. (23rd October 2018) Authors: Tavares, N T; Simões, J; Borges, C; Meireles, S; Costa, A; Fernandes, C; Caeiro, C; Damasceno, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗